Prescriber Bag Supplies
Federal · Australia · 51-200 Employees
View Company Info for Free
Overview
Headquarters
PO Box, Brisbane, Queensland, 4001, Aust...Phone Number
+61 1800552580Website
www.pbs.gov.auRevenue
$79.1 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
2
2
1
1
1
About Prescriber Bag Supplies
The Pharmaceutical Benefits Scheme (PBS) provides information on medicines subsidized by the Australian Government, catering to consumers, health professionals, and the pharmaceutical industry. It includes a comprehensive A-Z listing of medicines, guidelines for prescribers and pharmacists, and resources for industry stakeholders. The PBS is managed by the Department of Health, Disability and Ageing, ensuring access to affordable medications for patients. Additionally, it offers updates on prescription changes and various health programs.Explore more
Popular SearchesPrescriber Bag SuppliesPharmaceutical Benefits SchemePBS ServicesSIC Code 94,943NAICS Code 92,923Show morePrescriber Bag Supplies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Prescriber Bag Supplies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Prescriber Bag Supplies is spiking on competitors!
Click to see if Prescriber Bag Supplies had a recent Job posting/layoffs
Prescriber Bag Supplies, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Prescriber Bag Supplies has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Prescriber Bag Supplies has new funding data
Product Launch: Get notified when Prescriber Bag Supplies launches new products
Congratulate Masked Content for being promoted to Masked Content at Prescriber Bag Supplies
Earning: See what the market has to say on Prescriber Bag Supplies recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Prescriber Bag Supplies as Masked Content
Find 2 more new buyers
Compare Similar Companies to Prescriber Bag Supplies
Compare insights from companies similar to Prescriber Bag Supplies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Prescriber Bag Supplies is experiencing very low activity levels compared to other companies in the Government sector.
What does this means?
Prescriber Bag Supplies is drawing exceptional interest within the Government industry, suggesting notable developments or strong market momentum, learn more about Prescriber Bag Supplies.
Prescriber Bag Supplies Tech Stack
A closer look at the technologies used by Prescriber Bag Supplies
Prescriber Bag Supplies News & Media
New treatment for severe corneal inflammation from DED now listed on PBS
MELBOURNE, Oct 1, 2021 - (ACN Newswire) - Today, adults living with severe corneal inflammation from DED (dry eye disease) gain access to a new treatment on the PBS. Ikervis(R), Australia's first PBS listed disease-modifying ciclosporin eye drop treatment for severe keratitis in adults with DED, is now available (1 October 2021). In-licensed for the first time in Australia by Seqirus, a wholly-owned subsidiary of CSL, from leading ophthalmic company Santen Pharmaceutical Co Ltd, IkervisNew treatment option for schizophrenia Reagila(R) listed on PBS
MELBOURNE, Sep 6, 2021 - (ACN Newswire) - A new treatment for schizophrenia in adults, Reagila(R) (cariprazine), was listed on the Pharmaceutical Benefits Scheme (PBS) on 1 September, providing patients with an additional treatment option. Approved in the US since 2015 and EU since 2017, Reagila is approved in over 52 countries for the treatment of schizophrenia in adults. Schizophrenia is a complex psychiatric disorder comprising a range of symptoms - positive symptoms include hallucinationsNew treatment option for schizophrenia - Reagila(R) - listed on PBS this week
MELBOURNE, Sep 3, 2021 - (ACN Newswire) - A new treatment for schizophrenia in adults, Reagila(R)(cariprazine), was listed on the Pharmaceutical Benefits Scheme (PBS) on 1 September, 2021, providing patients with an additional treatment option.1 Schizophrenia is a complex psychiatric disorder2 comprising a range of symptoms, including positive symptoms, such as hallucinations and delusions,6,7 and negative symptoms, such as social withdrawal and apathy.8,9 Reagila(R) - in-licensed by Seqirus, a
Read more news
Top Federal Companies
Frequently Asked Questions Regarding Prescriber Bag Supplies
Sign Up For FreeTo access detailed company insights
The Pharmaceutical Benefits Scheme (PBS) provides information on medicines subsidized by the Australian Government, catering to consumers, health professionals, and the pharmaceutical industry. It includes a comprehensive A-Z listing of medicines, guidelines for prescribers and pharmacists, and resources for industry stakeholders. The PBS is manage... Read More
